Literature DB >> 7665870

Fibrosing cholestatic hepatitis in a renal transplant recipient associated with the hepatitis B virus precore mutant.

J C Booth1, R D Goldin, J L Brown, P Karayiannis, H C Thomas.   

Abstract

A patient with evidence of chronic infection with hepatitis B virus (seropositive for hepatitis B surface antigen, and with antibody to hepatitis B e antigen) underwent renal transplantation, which subsequently failed. The patient developed abnormal liver function tests and 8 months after the removal of the transplanted kidney, hepatitis B virus DNA was detected in the serum in the absence of hepatitis B e antigen. Liver biopsy revealed the presence of fibrosing cholestatic hepatitis. Sequence analysis of the serum hepatitis B virus DNA showed the presence of the pre-core mutant. This case shows that fibrosing cholestatic hepatitis can occur outside the setting of liver transplantation, and coincided with the development of the pre-core mutant of hepatitis B virus.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7665870     DOI: 10.1016/0168-8278(95)80116-2

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  5 in total

1.  Fibrosing Cholestatic Hepatitis Following Renal Transplantation in a Patient Infected With the Hepatitis B Virus.

Authors:  Sascha Goonewardena; Andrew S Ross
Journal:  Gastroenterol Hepatol (N Y)       Date:  2006-03

Review 2.  Fibrosing cholestatic hepatitis in renal transplant recipient with CMV infection: a case report.

Authors:  S K Agarwal; V Kalra; Amit Dinda; S Gupta; S C Dash; D Bhowmik; S C Tiwari
Journal:  Int Urol Nephrol       Date:  2004       Impact factor: 2.370

3.  A YIDD Mutation in a Case of Recurrent Hepatitis B after Liver Transplantation Induced by an S-escape Mutant.

Authors:  Yun-Jung Oh; Young-Min Park; Sun-Pyo Hong; Soo-Kyeong Shin; Seung-Il Ji; Bo-Hyun Kim; Sang-Jong Park; Zheng Hong
Journal:  Gut Liver       Date:  2010-06-16       Impact factor: 4.519

4.  Fibrosing cholestatic hepatitis following cytotoxic chemotherapy for small-cell lung cancer.

Authors:  Jaime Ceballos-Viro; José-M López-Picazo; José-L Pérez-Gracia; Jesús-J Sola; Gregorio Aisa; Ignacio Gil-Bazo
Journal:  World J Gastroenterol       Date:  2009-05-14       Impact factor: 5.742

5.  Seronegative hepatitis C-related fibrosing cholestatic hepatitis after renal transplant: a case report and review of the literature.

Authors:  Nathan J Shores; James Kimberly
Journal:  NDT Plus       Date:  2008-04-05
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.